GlassScriptPhysician profile
Warren R Banach
NPI 1144202284
$905.19
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $201 · 2022: $65.19.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $236.31 | 2019-2020 | |
| Astellas Pharma US INC | $157.51 | 2019-2020 | |
| Pfizer INC. | $125.20 | 2019-2020 | |
| Coopersurgical, INC. | $66.51 | 2019 | |
| Amgen INC. | $64.88 | 2019-2020 | |
| Hologic Sales and Service, LLC | $49.65 | 2019-2020 | |
| Lupin INC. | $43.02 | 2019 | |
| Becton, Dickinson and Company | $33.35 | 2020-2022 | |
| Ethicon US, LLC | $32.80 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.46 | 2019-2020 | |
| Olympus America INC. | $16.48 | 2019 | |
| Duchesnay USA Incorporated | $15.76 | 2019 | |
| Organon LLC | $13.83 | 2022 | |
| Therapeuticsmd, INC. | $11.92 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Banach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.